Unlocking Cures for Pediatric Cancer with Artificial Intelligence
Directs the use of AI technologies in federal cancer research programs to accelerate the development of treatments for pediatric cancers.
Section by Section
What each section does, and how they differ.
Establishes the MAHA Commission goal to accelerate AI innovation in pediatric cancer research and treatment in coordination with NIH and other agencies.
Directs the MAHA Commission and APST to coordinate with federal agencies and private sector to expand AI-driven pediatric cancer research and clinical applications.
Tasks MAHA Commission and NIH to identify strategies for increasing federal investment in pediatric cancer initiatives and encouraging private AI innovation in treatments.
Directs HHS to work with APST to integrate AI into health data interoperability efforts, maximize electronic health record and claims data for research, and finalize AI-focused data standards.
Defines artificial intelligence for purposes of this order consistent with federal AI policy frameworks.
Standard boilerplate: preserves existing agency authority, conditions the order on appropriations, and creates no enforceable private rights.